Volume 6 Supplement 1
15th Paediatric Rheumatology European Society (PreS) Congress
Meeting abstracts
Edited by Wietse Kuis, Patricia Woo, Angelo Ravelli, Hermann Girschick, Michaël Hofer, Johannes Roth, Rotraud K Saurenmann, Alberto Martini, Pavla Dolezova, Janjaap van der Net, Pierre Quartier, Lucy Wedderburn and Jan Scott
15th Paediatric Rheumatology European Society (PreS) Congress. Go to conference site.
London, UK14-17 September 2008
Page 1 of 7
-
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S1
-
Analysis of the classical, alternative, and MBL pathways of the complement system in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P1 -
2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S2 -
The Damage Associated Molecular Pattern (DAMP) molecule S100A12 induces pro-inflammatory responses in monocytes via innate immunity signalling pathways
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P2 -
2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S3 -
The influencing of environmental and genetics factors on bone metabolism in juvenile idiopathic arthritis children
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P3 -
2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S4 -
May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis?
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P4 -
2.5 Mesenchymal Stem Cell Therapy has significant clinical effect in proteoglycan induced arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S5 -
A juvenile idiopathic arthritis biobank at the Royal Children's Hospital, Melbourne, Australia
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P5 -
3.4 Physical activity in adolescents with juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S6 -
Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P6 -
3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S7 -
Are genetic variants of Caspase-1 and Cryopyrin associated with systemic JIA?
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P7 -
4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S8 -
Role of Vγ9Vδ2+ γδ T cells in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P8 -
4.5 Defective phosphorylation of the interleukin 18 receptor beta-chain causes impaired NK cell function in systemic onset Juvenile Idiopathic Arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S9 -
Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P9 -
6.4 Spondylo-epiphyseal dysplasia – a physiotherapy approach
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S10 -
CD39: a regulatory role in childhood arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P10 -
7.1 Transgenic overexpression of CREM alpha in murine T cells results in an anergic phenotype with enhanced IL17 production
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S11 -
The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P11 -
7.2 Interleukin-17 (IL-17) secreting cells in synovial fluid express the "Th17" master transcription factor RORC and their numbers correlate with CCL20 levels within the joint
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S12 -
The role of synovial fluid cytokines IL-6, IL-23 and IL-17 in the pathogenesis and persistence of synovial inflammation in JIA patients
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P12 -
7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S13 -
FOXP3 expression in peripheral blood and synovial cells of patients with juvenile idiopathic arthritis: relationship with IL-17 at cytokine and molecular level
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P13 -
7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S14 -
Association between IL2RA and juvenile idiopathic arthritis (JIA) disease severity at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study (CAPS)
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P14 -
7.5 Safety data from over 1,200 patients-years of methotrexate and/or etanercept treatment in children with polyarticular or systemic juvenile rheumatoid arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S15 -
Single-nucleotide polymorphisms in the folate pathway are associated with response to methotrexate treatment in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P15 -
7.6 Long-term treatment with glucocorticoids and low bone mass: a longitudinal study in 266 children and adolescents
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S16 -
MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P16 -
8.3 Disease patterns in Danish Juvenile Dermatomyositis patients
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S17 -
High membrane expression of CD163 by bone marrow cells is not a specific marker of macrophage activation syndrome (MAS)
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P17 -
8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S18 -
Lymph act, TCR αβ, TCR γδ cells in peripheral blood in children with juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P18 -
8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S19 -
Activated CD27+ and CD27- memory B cells accumulate in the joints of patients with juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P19 -
Abstract withdrawn
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P20 -
9.1 Innate resistance of endothelial cells to the effects of glucocorticoids
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S20 -
9.2 QT interval dispersion in North Indian children with Kawasaki disease
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S21 -
Characterization of B cells in synovial fluid and tissue from patients with JIA
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P21 -
9.3 Endothelial progenitor cells and vasculogenic responses to therapy in children with primary systemic vasculitis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S22 -
Methotrexate in childhood arthritis: effects on gene expression
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P22 -
Methotrexate does not primarily affect Foxp3+ regulatory T cells in poly-articular juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P23 -
9.4 Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, autoantibody clustering and clinical correlations
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S23 -
12.2 Mevalonate kinase deficiency: Impaired isoprenoid synthesis induces IL-1beta production via activation of Rac1
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S24 -
Outcome of repeat dosing of sJIA patients with tocilizumab in one UK centre
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P24 -
12.3 Long-term follow up of patients with CINCA syndrome: efficacy and tolerability of Anakinra treatment
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S25 -
Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P25
Official journal of
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.8
5-year Journal Impact Factor: 2.8
Source Normalized Impact per Paper (SNIP): 0.966
SCImago Journal Rank (SJR): 0.835Speed 2023
Submission to first editorial decision (median days): 18
Submission to acceptance (median days): 94Usage 2023
Downloads: 1,095,144
Altmetric mentions: 691